NCT00047515已完成3 期
Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-69.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.
- •Clinically relevant ophthalmic or systemic conditions may be excluded.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41Ocular HypertensionOpen-Angle GlaucomaNCT00047528Alcon Research
已完成
3 期
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70Ocular HypertensionOpen-Angle GlaucomaNCT00047541Alcon Research
已完成
2 期
Clinical Study of A Fixed Combination of Timolol-Brimonidine-DorzolamidePrimary Open Angle GlaucomaOcular HypertensionNCT01062971Laboratorios Sophia S.A de C.V.124
Unknown
3 期
A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular HypertensionOcular HypertensionPrimary Open Angle GlaucomaNCT04863365pH Pharma110
已完成
2 期
Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension GlaucomaNormal Tension GlaucomaNCT03106532pH Pharma119